---
figid: PMC6675034__PO.17.00198app4
figtitle: Full candidate pathway that represents molecular drivers of tumorigenesis
  in the sarcoma of patient 1
organisms:
- NA
pmcid: PMC6675034
filename: PO.17.00198app4.jpg
figlink: pmc/articles/PMC6675034/figure/fA.4/
number: AF4
caption: 'Full candidate pathway that represents molecular drivers of tumorigenesis
  in the sarcoma of patient 1. We reconstructed this pathway on the basis of the outlier
  analysis, differential gene expression analysis, copy number information and literature
  mining (Appendix Methods). A simplified version of this pathway is presented in
  . Both EWSR1-ATF1 and receptor tyrosine kinases PDGFRB, NTRK1, ALK, and FGFR1 can
  contribute to the activation of IL6/JAK/STAT3 signaling. All gene expression outliers
  depicted in this figure were significant in all three comparisons: patient 1 versus
  all cancers, patient 1 versus lung adenocarcinomas, and patient 1 versus sarcomas.
  JAK1, the molecular target of ruxolitinib, is indicated with a yellow lightning
  bolt. TCGA, The Cancer Genome Atlas.'
papertitle: Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With
  Relapsed Cancer.
reftext: Yulia Newton, et al. JCO Precis Oncol. 2018;2:PO.17.00198.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8462251
figid_alias: PMC6675034__AF4
figtype: Appendix figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6675034__AF4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6675034__PO.17.00198app4.html
  '@type': Dataset
  description: 'Full candidate pathway that represents molecular drivers of tumorigenesis
    in the sarcoma of patient 1. We reconstructed this pathway on the basis of the
    outlier analysis, differential gene expression analysis, copy number information
    and literature mining (Appendix Methods). A simplified version of this pathway
    is presented in . Both EWSR1-ATF1 and receptor tyrosine kinases PDGFRB, NTRK1,
    ALK, and FGFR1 can contribute to the activation of IL6/JAK/STAT3 signaling. All
    gene expression outliers depicted in this figure were significant in all three
    comparisons: patient 1 versus all cancers, patient 1 versus lung adenocarcinomas,
    and patient 1 versus sarcomas. JAK1, the molecular target of ruxolitinib, is indicated
    with a yellow lightning bolt. TCGA, The Cancer Genome Atlas.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EWSR1
  - SH3RF1
  - SLC1A1
  - TOP2A
  - ARNT2
  - CALCA
  - CALCB
  - PTGS2
  - IL6
  - MMP1
  - AURKA
  - IL6R
  - NTRK1
  - ALK
  - PTEN
  - PIK3R2
  - JAK1
  - MTOR
  - CCND1
  - EIF4EBP1
  - BCL11B
  - BIRC5
  - ETS2
  - ATF1
  - GDNF
  - TCGA
  - O
  - sarcoma
  - lung adenocarcinoma cohort
  - cancer
---
